Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PharmaNutra is an Italian pharmaceutical company specializing in the development of mineral-based nutritional supplements and medical devices. The company is best known for its proprietary Sucrosomial Technology, which enhances the absorption and bioavailability of minerals like iron, magnesium, and zinc while reducing gastrointestinal side effects. Its flagship product line, SiderAL, has established the company as a leader in the oral iron replacement market. PharmaNutra also develops topical treatments for joint and muscle pain under the Cetilar brand, utilizing Cetylated Fatty Acids. The company operates through a business model that includes direct sales in Italy and international distribution partnerships across more than 70 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmanutra Ingredients.